Deals to restrain generic drugs face a ban in healthcare bill

New York Times, January 13, 2010

A group of House lawmakers and the head of the Federal Trade Commission want Congress to include a provision in the healthcare legislation that they say could save American consumers several billion dollars a year on prescription drugs, the New York Times reports. The group plans to ask Congress to block business deals in which they say makers of name-brand drugs directly or indirectly pay generic makers to delay competition from cheaper generic alternatives. The House bill already includes such a ban.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.